Financial statements Madson Pharma
Balance sheet data of MADSON PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 127 515,87 | 149 935,67 | 171 826,60 | 580 852,76 | 1 376 968,79 | 1 572 291,77 |
| A. Fixed assets | 77 000,00 | 77 000,00 | 77 000,00 | 77 000,00 | 77 000,00 | 77 000,00 |
| B. Current assets | 50 515,87 | 72 935,67 | 94 826,60 | 503 852,76 | 1 299 968,79 | 1 495 291,77 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 127 515,87 | 149 935,67 | 171 826,60 | 580 852,76 | 1 376 968,79 | 1 572 291,77 |
| A. Equity | 18 154,00 | 45 622,80 | 66 932,73 | 107 988,77 | 262 617,45 | 614 032,15 |
| B. Liabilities and provisions for liabilities | 109 361,87 | 104 312,87 | 104 893,87 | 472 863,99 | 1 114 351,34 | 958 259,62 |
| I. Long-term liabilities | 0,00 | 101 845,87 | 101 845,87 | 101 845,87 | 101 845,87 | 100 622,87 |
| II. Short-term liabilities | 14 361,87 | 2 467,00 | 3 048,00 | 371 018,12 | 1 012 505,47 | 857 636,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.